BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Merja Bläuer, Matias Laaninen, Juhani Sand, Johanna Laukkarinen. Wnt/β-catenin signalling plays diverse functions during the process of fibrotic remodelling in the exocrine pancreasPancreatology 2019; 19(2): 252 doi: 10.1016/j.pan.2019.02.003
2
YOUTU WU, CHUNHUI LIU, SHENGYUAN YU, HUA GAO, ZHENYE LI, CHUZHONG LI, YAZHUO ZHANG. Assessment of sFRP4 as a bio-marker for predicting aggressiveness and recurrence of growth hormone-secreting pituitary adenomasOncology Reports 2016; 35(5): 2991 doi: 10.3892/or.2016.4650
3
Ye Zhang, Bin Yang, Zhi Du, Ying-Tang Gao, Yi-Jun Wang, Xiang Jing, Tong Bai. Identification and validation of specific methylation profile in bile for differential diagnosis of malignant biliary strictureClinical Biochemistry 2010; 43(16-17): 1340 doi: 10.1016/j.clinbiochem.2010.08.013
4
Jian Zhu, Yuyan Wang, Jianchun Duan, Hua Bai, Zhijie Wang, Lai Wei, Jun Zhao, Minglei Zhuo, Shuhang Wang, Lu Yang, Tongtong An, Meina Wu, Jie Wang. DNA Methylation status of Wnt antagonist SFRP5 can predict the response to the EGFR-tyrosine kinase inhibitor therapy in non-small cell lung cancerJournal of Experimental & Clinical Cancer Research 2012; 31(1): 80 doi: 10.1186/1756-9966-31-80
5
Iris Gehrke, Rajesh Kumar Gandhirajan, Karl-Anton Kreuzer. Targeting the WNT/β-catenin/TCF/LEF1 axis in solid and haematological cancers: Multiplicity of therapeutic optionsEuropean Journal of Cancer 2009; 45(16): 2759 doi: 10.1016/j.ejca.2009.08.003
6
H Listing, W A Mardin, S Wohlfromm, S T Mees, J Haier. MiR-23a/-24-induced gene silencing results in mesothelial cell integration of pancreatic cancerBritish Journal of Cancer 2015; 112(1): 131 doi: 10.1038/bjc.2014.587
7
Jana Reins, Maximilian Mossner, Martin Neumann, Uwe Platzbecker, Christiane Schumann, Eckhard Thiel, Wolf-Karsten Hofmann. Transcriptional down-regulation of the Wnt antagonist SFRP1 in haematopoietic cells of patients with different risk types of MDSLeukemia Research 2010; 34(12): 1610 doi: 10.1016/j.leukres.2010.04.013
8
Rajesh Singh, James W. Lillard, Shailesh Singh. Epigenetic Advancements in Cancer2016; : 27 doi: 10.1007/978-3-319-24951-3_2
9
Chenghai Zhao, Haiying Ma, Xianmin Bu, Wei Wang, Ning Zhang. SFRP5 inhibits gastric epithelial cell migration induced by macrophage-derived Wnt5aCarcinogenesis 2013; 34(1): 146 doi: 10.1093/carcin/bgs309
10
Sebastian Pohl, Ross Scott, Frank Arfuso, Vanathi Perumal, Arun Dharmarajan. Secreted frizzled-related protein 4 and its implications in cancer and apoptosisTumor Biology 2015; 36(1): 143 doi: 10.1007/s13277-014-2956-z
11
Alexandra Filipovich, Iris Gehrke, Simon J. Poll-Wolbeck, Karl-Anton Kreuzer. Physiological inhibitors of Wnt signalingEuropean Journal of Haematology 2011; 86(6): 453 doi: 10.1111/j.1600-0609.2011.01592.x
12
D. Wehrum, A. Hartmann, R. Stoehr, R. Gruetzmann, C. Pilarsky, H.D. Saeger. Chirurgisches Forum und DGAV Forum 2010Deutsche Gesellschaft für Chirurgie 2010; 39: 53 doi: 10.1007/978-3-642-12192-0_20
13
Xu Han, Hexige Saiyin, Junjie Zhao, Yuan Fang, Yefei Rong, Chenye Shi, Wenhui Lou, Tiantao Kuang. Overexpression of miR-135b-5p promotes unfavorable clinical characteristics and poor prognosis via the repression of SFRP4 in pancreatic cancerOncotarget 2017; 8(37): 62195 doi: 10.18632/oncotarget.19150
14
Stefan David, Stephen J. Meltzer. Pre-Invasive Disease: Pathogenesis and Clinical Management2011; : 41 doi: 10.1007/978-1-4419-6694-0_4
15
Masahiro Gotoh, Eri Arai, Saori Wakai-Ushijima, Nobuyoshi Hiraoka, Tomoo Kosuge, Fumie Hosoda, Tatsuhiro Shibata, Tadashi Kondo, Sana Yokoi, Issei Imoto, Johji Inazawa, Yae Kanai. Diagnosis and Prognostication of Ductal Adenocarcinomas of the Pancreas Based on Genome-Wide DNA Methylation Profiling by Bacterial Artificial Chromosome Array-Based Methylated CpG Island AmplificationJournal of Biomedicine and Biotechnology 2011; 2011: 1 doi: 10.1155/2011/780836
16
Shilong Han, Chuanwu Cao, Tao Tang, Chenhui Lu, Jichong Xu, Shi Wang, Lei Xue, Xiaoping Zhang, Maoquan Li. ROBO3 promotes growth and metastasis of pancreatic carcinomaCancer Letters 2015; 366(1): 61 doi: 10.1016/j.canlet.2015.06.004
17
Youtu Wu, Jiwei Bai, Zhenye Li, Fei Wang, Lei Cao, Chunhui Liu, Shengyuan Yu, Guoqiang Yu, Yazhuo Zhang. Low expression of secreted frizzled-related protein 4 in aggressive pituitary adenomaPituitary 2015; 18(3): 335 doi: 10.1007/s11102-014-0579-4
18
Rabab M. Aly, Mona M. Taalab, Eman M. Abdsalam. Prognostic Significance of Secreted Frizzled-Related Protein 2 Expression in Cytogenetically Normal Primary Acute Myeloid LeukemiaThe American Journal of the Medical Sciences 2015; 350(5): 369 doi: 10.1097/MAJ.0000000000000567
19
Jongbum Kim, Sangsoo Kim. In silicoIdentification ofSFRP1as a Hypermethylated Gene in Colorectal CancersGenomics & Informatics 2014; 12(4): 171 doi: 10.5808/GI.2014.12.4.171
20
Salvatore Chirumbolo, Geir Bjørklund. Can Wnt5a and Wnt non-canonical pathways really mediate adipocyte de-differentiation in a tumour microenvironment?European Journal of Cancer 2016; 64: 96 doi: 10.1016/j.ejca.2016.05.026
21
Rohit Surana, Sakshi Sikka, Wanpei Cai, Eun Myoung Shin, Sudha R. Warrier, Hong Jie Gabriel Tan, Frank Arfuso, Simon A. Fox, Arun M. Dharmarajan, Alan Prem Kumar. Secreted frizzled related proteins: Implications in cancersBiochimica et Biophysica Acta (BBA) - Reviews on Cancer 2014; 1845(1): 53 doi: 10.1016/j.bbcan.2013.11.004
22
Sohei Kitazawa, Ryuma Haraguchi, Riko Kitazawa. Morphology-oriented epigenetic researchHistochemistry and Cell Biology 2018; 150(1): 3 doi: 10.1007/s00418-018-1675-8
23
Priscilla Brebi, Rene Hoffstetter, Alejandra Andana, Carmen G. Ili, Kathleen Saavedra, Tamara Viscarra, Javier Retamal, Raul Sanchez, Juan C. Roa. Evaluation ofZAR1andSFRP4methylation status as potentials biomarkers for diagnosis in cervical cancer: exploratory study phase IBiomarkers 2014; 19(3): 181 doi: 10.3109/1354750X.2013.867535
24
Stine Dam Henriksen, Poul Henning Madsen, Anders Christian Larsen, Martin Berg Johansen, Inge Søkilde Pedersen, Henrik Krarup, Ole Thorlacius-Ussing. Cell-free DNA promoter hypermethylation in plasma as a predictive marker for survival of patients with pancreatic adenocarcinomaOncotarget 2017; 8(55): 93942 doi: 10.18632/oncotarget.21397